Statin-dependent modulation of mitochondrial metabolism in cancer cells is independent of cholesterol content.
Christie CF, Fang D, Hunt EG, Morris ME, Rovini A, Heslop KA, Beeson GC, Beeson CC, Maldonado EN.
Christie CF, et al. Among authors: rovini a.
FASEB J. 2019 Jul;33(7):8186-8201. doi: 10.1096/fj.201802723R. Epub 2019 Apr 5.
FASEB J. 2019.
PMID: 30951369
Free PMC article.
Statins, widely used to treat hypercholesterolemia, inhibit the 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting enzyme of de novo cholesterol (Chol) synthesis. Statins have been also reported to slow tumor progression. ...F., Fang, D., Hunt, E. G., Morri …
Statins, widely used to treat hypercholesterolemia, inhibit the 3-hydroxy-3-methylglutaryl-coenzyme A reductase, the rate-limiting en …